Riskpilot← Back to searchSign inGet full accessRoth-Med Oy
OYDissolvedY-tunnus 2220924-3Pohjoinen Hesperiankatu 37-B41Medical specialists activities · NACE 8622Est. 20082 employees
Revenue 2025
EUR 913K
-13% vs 2024
EBITDA margin
25.4%
+8% vs 2024
Equity ratio
98.4%
Financial strength
Net profit 2025
EUR 181K
+7% vs 2024
| Revenue | EUR 913K | -13% |
| EBITDA | EUR 232K | +8% |
| Net profit | EUR 181K | +7% |
| Total assets | EUR 849K | +16% |
| Equity | EUR 835K | +17% |
| Employees | 2 | — |
Legal name
Roth-Med Oy
Y-tunnus number
2220924-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
23. syyskuuta 2008
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiö tuottaa terveyden- ja sairaudenhoitopalveluja sisältäen lääkäri- ja psykoterapeuttipalvelut. Se tuottaa alan tutkimus-, koulutus-, luento- ja konsultointipalvelua. Yhtiön toimialaan kuuluu myös alan kirjallisuuden tuottaminen ja julkaiseminen. Yhtiön toimialaan kuluu ostaa, myydä, vuokrata kiinteää ja irtainta omaisuutta, hallita ja vuokrata asunto- ja kiinteistöosakehuoneistoja sekä harjoittaa arvopaperikauppaa.
Address
Pohjoinen Hesperiankatu 37-B41
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 175 | 978 | 983 | 1 045 | 913 |
| Staff expenses | −123 | −118 | −24 | −68 | −10 |
| EBITDA | 260 | 69 | 277 | 215 | 232 |
| Depreciation & amort. | −19 | −9 | −7 | −16 | −15 |
| EBIT | 241 | 60 | 270 | 199 | 217 |
| Net financials | −4 | 64 | 9 | 11 | 9 |
| Profit before tax | 237 | 123 | 279 | 210 | 226 |
| Tax | 48 | 29 | 55 | 41 | 45 |
| Net profit | 189 | 95 | 223 | 169 | 181 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 009 | 754 | 723 | 730 | 849 |
| Equity | 745 | 750 | 713 | 712 | 835 |
| Long-term debt | 164 | 0 | 0 | 0 | 0 |
| Short-term debt | 100 | 4 | 10 | 19 | 14 |
| Total debt | 264 | 4 | 10 | 19 | 14 |
EBITDA margin
25.4%
This company
15.8%
Market median
+61% vs market
20212025
Equity ratio
98.4%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
21.7%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
19.9%
This company
8.1%
Market median
+146% vs market
20212025
Asset turnover
1.08×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TT | Audit | 2021 |
TM Deputy auditor | Deputy auditor | 2021 |
KE Chief Executive Officer | Chief Executive Officer | 2020 |
JM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
| Former (2) | ||
MT Deputy auditor | Deputy auditor | 2008 – 2021 |
| Audit | 2008 – 2021 | |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Roth-Med Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marja-Leena Turunen | Deputy auditor | 0 companies |
| Tarja Tuulikki Tolvanen | Audit | 0 companies |
| Tarja Maarit Anita Lindroth | Deputy auditor | 0 companies |
| Kaarina Eira Roth | Chief Executive Officer | 0 companies |
| Joonas Matthias Roth | Deputy Chief Executive Officer | 0 companies |
| Riitta Tellervo Kallio-Saukkonen | Audit | 0 companies |
| Wolf-Dieter Roth | Chairperson | 0 companies |